AMENDMENT NO. 1 TO THE CREDIT AGREEMENTThe Credit Agreement • August 19th, 2022 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances)
AMENDMENT NO. 1 to the CREDIT AGREEMENT, dated as of August 18, 2022 (this “Amendment”), among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the Guarantors (as defined in the Credit Agreement), each L/C Issuer from time to time party hereto, BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and swing line lender (in such capacity, the “Swing Line Lender”), and each Increase Loan Lender (as defined below);
